Publications

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.

RODRIGUES, LC; Pereira, SM; Cunha, SS; Genser, B; Ichihara, MY; De Brito, SC; Hijjar, MA; Dourado, I; Cruz, AA; Sant'Anna, C; Bierrenbach, AL; Barreto, ML;

2005

Lancet, (2005).366 9493 10.1016/S0140-6736(05)67145-0.

Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals.

Bethony, J; Loukas, A; Smout, M; BROOKER, S; Mendez, S; Plieskatt, J; Goud, G; Bottazzi, ME; Zhan, B; Wang, Y; Williamson, A; Lustigman, S; Correa-Oliveira, R; Xiao, S; Hotez, PJ;

2005

FASEB journal, (2005).19 12 10.1096/fj.05-3936fje.

Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A.

SCOTT, JA G; Mlacha, Z; Nyiro, J; Njenga, S; Lewa, P; Obiero, J; Otieno, H; Sampson, JS; Carlone, GM;

2005

Clinical and diagnostic laboratory immunology, (2005).12 10 10.1128/CDLI.12.10.1195-1201.2005.

Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil.

Barreto, ML; Cunha, SS; Pereira, SM; Genser, B; Hijjar, MA; Yury Ichihara, M; De Brito, SC; Dourado, I; Cruz, A; Santa'Ana, C; RODRIGUES, LC;

2005

The international journal of tuberculosis and lung disease, (2005).9 10

The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Welte, R; Trotter, CL; EDMUNDS, WJ; Postma, MJ; Beutels, P;

2005

PharmacoEconomics, (2005).23 9 10.2165/00019053-200523090-00001.

Modelling the hepatitis B vaccination programme in prisons.

Sutton, AJ; Gay, NJ; EDMUNDS, WJ; Andrews, NJ; HOPE, VD; Gilbert, RL; Piper, M; Gill, ON;

2005

Epidemiology and infection, (2005).134 2 10.1017/S0950268805005182.

Reaching the unreached with measles vaccination.

Salama, P; McFarland, J; MULHOLLAND, K;

2005

Lancet, (2005).366 9488 10.1016/S0140-6736(05)67191-7.

Malaria vaccines. Evaluation and implementation.

GREENWOOD, B;

2005

Acta tropica, (2005).95 3 10.1016/j.actatropica.2005.04.017.

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

Melegaro, A; EDMUNDS, WJ;

2004

Vaccine, (2004).22 31-32 10.1016/j.vaccine.2004.05.003.

The seroepidemiology of Bordetella pertussis infection in Western Europe.

Pebody, RG; Gay, NJ; Giammanco, A; Baron, S; Schellekens, J; Tischer, A; Olander, RM; Andrews, NJ; EDMUNDS, WJ; Lecoeur, H; Lévy-Bruhl, D; Maple, PA C; De Melker, H; Nardone, A; Rota, MC; Salmaso, S; Conyn-van Spaendonck, MA E; Swidsinski, S; MILLER, E;

2004

Epidemiology and infection, (2004).133 1 10.1017/s0950268804003012.